Común · Organizaciones
AtaiBeckley
American clinical-stage biopharmaceutical company focused on mental health treatments
AtaiBeckley Inc. is a clinical-stage biotechnology company developing treatments for mental health disorders, including therapies based on psychedelics, entactogens, and related compounds. It was formed in November 2025 through the combination of atai Life Sciences N.V. and Beckley Psytech Limited, and has been a wholly owned subsidiary of Eli Lilly and Company since September 2026.
En Wikipedia
Texto en inglés Aún no hay artículo en tu idioma: extracto en inglés.
AtaiBeckley Inc. is a clinical-stage biotechnology company developing treatments for mental health disorders, including therapies based on psychedelics, entactogens, and related compounds. It was formed in November 2025 through the combination of atai Life Sciences N.V. and Beckley Psytech Limited, and has been a wholly owned subsidiary of Eli Lilly and Company since September 2026.
Texto: Wikipedia en inglés, CC BY-SA 4.0. ·
Cartas cercanas
-
D★
Definium Therapeutics
American clinical-stage biopharmaceutical company developing psychedelic-based treatments
-
★
Intellia Therapeutics
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.
-
A★
Auticon
Tech company that employs autistic persons
-
★★
Biogen
Empresa multinacional de biotecnología estadounidense
-
★
Actelion
Compañía Farmacéutica
-
★★
Psicoterapia psicodélica